Novel strategies for relapsed and refractory acute myeloid leukemiaMATO, Anthony R; MORGANS, Alicia; LUGER, Selina M et al.Current opinion in hematology. 2008, Vol 15, Num 2, pp 108-114, issn 1065-6251, 7 p.Article

Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: Comparison with adult acute myeloid leukemiaVERSTOVSEK, Srdan; MANSHOURI, Taghi; SMITH, Franklin O et al.Cancer. 2003, Vol 97, Num 9, pp 2212-2217, issn 0008-543X, 6 p.Article

In vitro sensitivity of hematopoietic progenitors to Tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemiaCOLOVIC, M; SEFER, D; BOGDANOVIC, A et al.Cancer letters. 2003, Vol 195, Num 2, pp 153-159, issn 0304-3835, 7 p.Article

Prognostic factors and outcome of recurrence in childhood acute myeloid leukemiaRUBNITZ, Jeffrey E; RAZZOUK, Bassem I; LENSING, Shelly et al.Cancer. 2007, Vol 109, Num 1, pp 157-163, issn 0008-543X, 7 p.Article

A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemiaSUMI, M; TAUCHI, T; SASHIDA, G et al.International journal of oncology. 2004, Vol 24, Num 6, pp 1481-1487, issn 1019-6439, 7 p.Article

MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemiasLASA, A; CARNICER, M. J; AVENTIN, A et al.Leukemia. 2004, Vol 18, Num 7, pp 1231-1237, issn 0887-6924, 7 p.Article

Treating Octogenarian and Nonagenarian Acute Myeloid Leukemia Patients―Predictive Prognostic ModelsHARB, Antoine J; WEI TAN; WILDING, Gregory E et al.Cancer. 2009, Vol 115, Num 11, pp 2472-2481, issn 0008-543X, 10 p.Article

Deregulation of apoptosis in acute myeloid leukemiaTESTA, Ugo; RICCIONI, Roberta.Haematologica (Roma). 2007, Vol 92, Num 1, pp 81-94, issn 0390-6078, 14 p.Article

Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patientsAL-KALI, Aref; KONOPLEV, Sergej; BORTHAKUR, Gautam et al.Haematologica (Roma). 2012, Vol 97, Num 2, pp 235-240, issn 0390-6078, 6 p.Article

Progress in the treatment of acute myeloid leukemiaRAVANDI, Farhad; BURNETT, Alan K; AGURA, Edward D et al.Cancer. 2007, Vol 110, Num 9, pp 1900-1910, issn 0008-543X, 11 p.Article

New agents in acute myeloid leukemia and other myeloid disordersRAVANDI, Farhad; KANTARJIAN, Hagop; GILES, Francis et al.Cancer. 2004, Vol 100, Num 3, pp 441-454, issn 0008-543X, 14 p.Article

Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphomaOWATARI, Satsuki; OTSUKA, Maki; UOZUMI, Kimiharu et al.International journal of hematology. 2007, Vol 85, Num 1, pp 32-35, issn 0925-5710, 4 p.Article

Remission induction in acute myeloid leukemia : PIH: How to improve the outcome of adult acute myeloid leukemia?STEIN, Eytan M; TALLMAN, Martin S.International journal of hematology. 2012, Vol 96, Num 2, pp 164-170, issn 0925-5710, 7 p.Article

Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remissionBARON, Frederic; STORH, Bainer.Current opinion in hematology. 2007, Vol 14, Num 2, pp 145-151, issn 1065-6251, 7 p.Article

Impact of body-mass index on the outcome of adult patients with acute myeloid leukemiaMEDEIROS, Bruno C; OTHUS, Megan; ESTEY, Elihu H et al.Haematologica (Roma). 2012, Vol 97, Num 9, pp 1401-1404, issn 0390-6078, 4 p.Article

Landscape of TET2 mutations in acute myeloid leukemiaWEISSMANN, S; ALPERMANN, T; KERN, W et al.Leukemia. 2012, Vol 26, Num 5, pp 934-942, issn 0887-6924, 9 p.Article

Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patientsNICOLAS, E; RAMUS, C; CAHN, J. Y et al.Leukemia. 2011, Vol 25, Num 1, pp 57-65, issn 0887-6924, 9 p.Article

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia: The Start of an Era?PEMMARAJU, Naveen; KANTARJIAN, Hagop; RAVANDI, Farhad et al.Cancer. 2011, Vol 117, Num 15, pp 3293-3304, issn 0008-543X, 12 p.Article

Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemiaBALGOBIND, Brian V; HOLLINK, Iris H. I. M; ZEMANOVA, Zuzana et al.Haematologica (Roma). 2011, Vol 96, Num 10, pp 1478-1487, issn 0390-6078, 10 p.Article

High levels of CD34⁺CD38^low/-CD123⁺ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang (GOELAMS) studyVERGEZ, François; GREEN, Alexa S; DREYFUS, François et al.Haematologica (Roma). 2011, Vol 96, Num 12, pp 1792-1798, issn 0390-6078, 7 p.Article

Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemiaXIAOXIAN ZHAO; SINGH, Shweta; PARDOUX, Cecile et al.Haematologica (Roma). 2010, Vol 95, Num 1, pp 71-78, issn 0390-6078, 8 p.Article

Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropeniaZEIDLER, Cornelia; GERMESHAUSEN, Manuela; KLEIN, Christoph et al.British journal of haematology. 2009, Vol 144, Num 4, pp 459-467, issn 0007-1048, 9 p.Article

Current and Emerging Therapies for Acute Myeloid LeukemiaROBAK, Tadeusz; WIERZBOWSKA, Agnieszka.Clinical therapeutics. 2009, Vol 31, Num THEM, pp 2349-2370, issn 0149-2918, 22 p., 2Article

Alternative donor transplants for high-risk acute myeloid leukemiaGUPTA, Vikas.Current opinion in hematology. 2008, Vol 15, Num 2, pp 115-120, issn 1065-6251, 6 p.Article

Myeloid Sarcoma Is Associated With Superior Event-free Survival and Overall Survival Compared With Acute Myeloid LeukemiaTSIMBERIDOU, Apostolia-Maria; KANTARJIAN, Hagop M; SIJIN WEN et al.Cancer. 2008, Vol 113, Num 6, pp 1370-1378, issn 0008-543X, 9 p.Article